GSK
GSK American Depositary Shares Representing 2 Ordinary Shares
Stock
Stock
ISIN: US37733W2044
Ticker: GSK
US37733W2044
GSK
Price
Price
CHART BY
Historical dividends and forecast
GSK American Depositary Shares Representing 2 Ordinary Shares has so far distributed $0.79 in 2025. The next dividend will be paid on 10.07.2025
$1.609
CHART BY
Frequently asked questions
What is GSK American Depositary Shares Representing 2 Ordinary Shares's market capitalization?
The market capitalization of GSK American Depositary Shares Representing 2 Ordinary Shares is $106.02B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is GSK American Depositary Shares Representing 2 Ordinary Shares's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for GSK American Depositary Shares Representing 2 Ordinary Shares is 19.83. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for GSK American Depositary Shares Representing 2 Ordinary Shares?
GSK American Depositary Shares Representing 2 Ordinary Shares's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.638. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for GSK American Depositary Shares Representing 2 Ordinary Shares's stock?
Currently, 23 analysts cover GSK American Depositary Shares Representing 2 Ordinary Shares's stock, with a consensus target price of $58.57. Analyst ratings provide insights into the stock's expected performance.
What is GSK American Depositary Shares Representing 2 Ordinary Shares's revenue over the trailing twelve months?
Over the trailing twelve months, GSK American Depositary Shares Representing 2 Ordinary Shares reported a revenue of $54.45B.
Is GSK American Depositary Shares Representing 2 Ordinary Shares paying dividends?
Yes, GSK American Depositary Shares Representing 2 Ordinary Shares is paying dividends. The next payment is scheduled for 10.07.2025, with an expected amount of .
What is the EBITDA for GSK American Depositary Shares Representing 2 Ordinary Shares?
GSK American Depositary Shares Representing 2 Ordinary Shares's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $15.45B. EBITDA measures the company's overall financial performance.
What is the free cash flow of GSK American Depositary Shares Representing 2 Ordinary Shares?
GSK American Depositary Shares Representing 2 Ordinary Shares has a free cash flow of $8.58B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does GSK American Depositary Shares Representing 2 Ordinary Shares have, and what sector and industry does it belong to?
GSK American Depositary Shares Representing 2 Ordinary Shares employs approximately 68,629 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of GSK American Depositary Shares Representing 2 Ordinary Shares's shares?
The free float of GSK American Depositary Shares Representing 2 Ordinary Shares is 2.03B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $106.02B
- EPS (TTM)
- $2.638
- Free Float
- 2.03B
- P/E ratio (TTM)
- 19.83
- Revenue (TTM)
- $54.45B
- EBITDA (TTM)
- $15.45B
- Free Cashflow (TTM)
- $8.58B
Pricing
- 1D span
- $38.24$39.12
- 52W span
- $31.72$45.00
Analyst Ratings
The price target is $58.57 and the stock is covered by 23 analysts.
Buy
6
Hold
13
Sell
4
Information
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
- Employees
- 68,629
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US37733W2044
- Primary Ticker
- GSK
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet